Description
N-Acetyl Selank Amidate incorporates N-terminal acetylation and C-terminal amidation into the Selank heptapeptide scaffold, producing a highly stable derivative resistant to enzymatic degradation. This modification profile is studied in CNS research to compare receptor engagement kinetics, bioavailability, and anxiolytic-nootropic activity relative to unmodified Selank.
HPLC and MS/MS tested to 99%+ purity. COA provided.
For research use only. Not for human or veterinary consumption.




